Home/Filings/4/0000886163-12-000016
4//SEC Filing

Kazmi Syed 4

Accession 0000886163-12-000016

CIK 0000886163other

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 2:17 PM ET

Size

8.9 KB

Accession

0000886163-12-000016

Insider Transaction Report

Form 4
Period: 2012-02-09
Kazmi Syed
VP, Bus. Dev. & Strategic Plan
Transactions
  • Award

    Common Stock

    2012-02-09+4,00018,230 total
  • Award

    Incentive Stock Option (right to buy)

    2012-02-09$14.47/sh+16,866$244,05116,866 total
    Exercise: $14.47Exp: 2022-02-09Common Stock (16,866 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2012-02-09$14.47/sh+8,134$117,6998,134 total
    Exercise: $14.47Exp: 2022-02-09Common Stock (8,134 underlying)
Footnotes (1)
  • [F1]Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Optioned Shares per month thereafter.

Issuer

LIGAND PHARMACEUTICALS INC

CIK 0000886163

Entity typeother

Related Parties

1
  • filerCIK 0001406049

Filing Metadata

Form type
4
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 2:17 PM ET
Size
8.9 KB